Ergoteles’s Scholar Rock SRRK Stock Holding History

Ergoteles’s Portfolio SRRK Stock Details SRRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-138,300	Closed	-$759K	–	1966
2022 Q2	$759K	Buy	+138,300	New	+$993K	0.02%	663

Other funds holding SRRK

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Ergoteles's SRRK Position: Q3 2022 in Review

Ergoteles sold out of Scholar Rock (SRRK) in Q3 2022, closing a stake of 138,300 shares — an estimated $759K sold.

Ergoteles first reported a position in SRRK in Q2 2022 and held it in 1 quarter. The position peaked at $759K in Q2 2022. 85 funds tracked by Wall St. Rank hold SRRK as of Q3 2022.

Ergoteles reported no remaining Scholar Rock position as of Q3 2022 after selling out during the quarter.
Ergoteles sold 138,300 Scholar Rock shares in Q3 2022, an estimated $759K.
Ergoteles first reported a position in Scholar Rock in Q2 2022 and held it in 1 quarter.
Ergoteles's Scholar Rock position peaked at $759K in Q2 2022.
85 funds tracked by Wall St. Rank held Scholar Rock as of Q3 2022.

Based on Ergoteles's 13F filing for Q3 2022, filed 14 Nov 2022.